LCN2 and urinary bladder cancer: Kaplan-Meier analysis revealed significantly worse 5-year progression-free survival associated with a strong expression of MAGEA3 (36) LCN2/MMP-9 pathway has been associated with an aggressive phenotype of bladder cancer and the elevated NPV of this protein complex makes them candidate markers of exclusion test for bladder cancer (37).